Day of study | Score | Body areas with hair regrowth versus pre-administration assessment | Fluralaner tablets | Topical imidacloprid-moxidectin |
---|---|---|---|---|
Assessment prior to any study treatments | ||||
−2 | 1 | Alopecia > 0 to 50% of the body | 7/8 (87.5%) | 7/8 (87.5%) |
2 | Alopecia > 50 to ≤ 90% of the body | 1/8 (12.5%) | 1/8 (12.5%) | |
3 | Alopecia > 90% of the body | 0/8 (0.0%) | 0/8 (0.0%) | |
Hair regrowth after treatment on days 0, 28, and 56a and on day 84 | ||||
28 | 1 | > 0 to 50% hair regrowth | 2/8 (25.0%) | 5/8 (62.5%) |
2 | > 50 to ≤ 90% hair regrowth | 4/8 (50.0%) | 3/8 (37.5%) | |
3 | > 90% improvement | 2/8 (25.0%) | 0/8 (0.0%) | |
56 | 1 | > 0 to 50% | 0/7 (0.0%) | 4/8 (50.0%) |
2 | > 50 to ≤ 90% | 2/7 (28.6%) | 2/8 (25.0%) | |
3 | > 90% | 5/7 (71.4%) | 2/8 (25.0%) | |
84 | 1 | > 0 to 50% | 0/7 (0.0%) | 1/8 (12.5%) |
2 | > 50 to ≤ 90% | 0/7 (0.0%) | 2/8 (25.0%) | |
3 | > 90% | 7/7 (100.0%) | 5/8 (62.5%) |